122 related articles for article (PubMed ID: 7479669)
1. Therapeutic regimens in acute experimental pancreatitis in rats: effects of a protease inhibitor, a beta-agonist, and antibiotics.
Araida T; Frey CF; Ruebner B; Carlson J; King J
Pancreas; 1995 Aug; 11(2):132-40. PubMed ID: 7479669
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological studies of FUT-175, nafamstat mesilate. II. Effects on experimental acute pancreatitis].
Iwaki M; Ozeki M; Sato T; Suzuki K; Motoyoshi A; Suzuki S; Fujita M; Aoyama T
Nihon Yakurigaku Zasshi; 1984 Oct; 84(4):363-72. PubMed ID: 6210233
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats.
Iwaki M; Ino Y; Motoyoshi A; Ozeki M; Sato T; Kurumi M; Aoyama T
Jpn J Pharmacol; 1986 Jun; 41(2):155-62. PubMed ID: 2427760
[TBL] [Abstract][Full Text] [Related]
4. Effect of the oral administration of sepimostat mesilate on cerulein induced acute pancreatitis in rats.
Wang ZH; Manabe T; Ohshio G; Hirano T; Okada N; Imamura T; Kawaguchi Y; Yotsumoto F; Yamaki K; Imamura M
Arzneimittelforschung; 1995 Oct; 45(10):1082-6. PubMed ID: 8595064
[TBL] [Abstract][Full Text] [Related]
5. Nafamostat mesilate on the course of acute pancreatitis. Protective effect on peritoneal permeability and relation with supervening pulmonary distress.
Marotta F; Fesce E; Rezakovic I; Chui DH; Suzuki K; Idéo G
Int J Pancreatol; 1994 Aug; 16(1):51-9. PubMed ID: 7528762
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of therapeutic infusion of nafamostat mesilate (FUT-175) on hemodynamics in experimental acute pancreatitis.
Dobosz M; Sledzinski Z; Juszkiewicz P; Babicki A; Stanek A; Wajda Z; Basinski A
Hepatogastroenterology; 1991 Apr; 38(2):139-42. PubMed ID: 1855771
[TBL] [Abstract][Full Text] [Related]
7. [Effect of continuous arterial infusion of protease inhibitor on experimental acute pancreatitis induced by closed duodenal loop obstruction].
Kakugawa Y; Takeda K; Sunamura M; Kawaguchi S; Kobari M; Matsuno S
Nihon Shokakibyo Gakkai Zasshi; 1990 Jun; 87(6):1444-50. PubMed ID: 2214268
[TBL] [Abstract][Full Text] [Related]
8. Comparison of different treatment modalities in experimental pancreatitis in rats.
Kimura W; Meyer F; Hess D; Kirchner T; Fischbach W; Mössner J
Gastroenterology; 1992 Dec; 103(6):1916-24. PubMed ID: 1451985
[TBL] [Abstract][Full Text] [Related]
9. The effect of nafamostat mesilate (FUT-175) and gabexate mesilate (FOY) on multiorgan oxidant-antioxidant balance in acute experimental pancreatitis.
Dabrowski A; Gabryelewicz A
J Physiol Pharmacol; 1994 Sep; 45(3):455-65. PubMed ID: 7841457
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of nafamostat and imipenem on experimental acute pancreatitis in rats.
Naruse S; Wang Y; Kitagawa M; Ishiguro H; Seki Y; Ozaki T; Hayakawa T
Pancreas; 2000 Oct; 21(3):290-5. PubMed ID: 11039474
[TBL] [Abstract][Full Text] [Related]
11. [Effects of E-3123, a new protease inhibitor, on several protease activities and on experimental acute pancreatitis].
Miyamoto K; Hishinuma I; Nagakawa J; Nagaoka N; Yamanaka T; Wakabayashi T
Nihon Yakurigaku Zasshi; 1988 May; 91(5):285-93. PubMed ID: 3410375
[TBL] [Abstract][Full Text] [Related]
12. Effect of FOY-305 (camostate) on severe acute pancreatitis in two experimental animal models.
Lankisch PG; Pohl U; Göke B; Otto J; Wereszczynska-Siemiatkowska U; Gröne HJ; Rahlf G
Gastroenterology; 1989 Jan; 96(1):193-9. PubMed ID: 2909420
[TBL] [Abstract][Full Text] [Related]
13. The effects of nafamostat mesilate (FUT-175) on caerulein-induced acute pancreatitis in the rat.
Wisner JR; Ozawa S; Renner IG
Int J Pancreatol; 1989 May; 4(4):383-90. PubMed ID: 2732529
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of nafamostat mesilate on cellular and lysosomal fragility of acinar cells in rat cerulein pancreatitis.
Manabe T; Hirano T; Imanishi K; Ando K; Yotsumoto F; Tobe T
Int J Pancreatol; 1992 Oct; 12(2):167-72. PubMed ID: 1281204
[TBL] [Abstract][Full Text] [Related]
15. Prevention of the spread of experimental acute pancreatitis by intraductal administration of a synthetic protease inhibitor in dogs.
Wakayama T; Itoh T; Shibayama K; Idezuki Y
Am J Gastroenterol; 1989 Mar; 84(3):272-8. PubMed ID: 2465686
[TBL] [Abstract][Full Text] [Related]
16. Effects of pancreatic duct ligation and aging on acute taurocholate-induced pancreatitis. Experiments in the perfused pancreas in rats.
Kimura W; Okubo K; Han I; Kanai S; Matsushita A; Muto T; Miyasaka K
Int J Pancreatol; 1996 Apr; 19(2):117-27. PubMed ID: 8723554
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of AA-861 (5-lipoxygenase inhibitor) on experimental acute necrotizing pancreatitis in rats.
Kiriyama M; Izumi R; Miyazaki I
Int J Pancreatol; 1993 Jun; 13(3):201-8. PubMed ID: 7690378
[TBL] [Abstract][Full Text] [Related]
18. Effect of gentiopicroside on experimental acute pancreatitis induced by retrograde injection of sodium taurocholate into the biliopancreatic duct in rats.
Lv J; Gu WL; Chen CX
Fitoterapia; 2015 Apr; 102():127-33. PubMed ID: 25759121
[TBL] [Abstract][Full Text] [Related]
19. Gabexate mesilate (FOY) protects against ceruletide-induced acute pancreatitis in the rat.
Wisner JR; Renner IG; Grendell JH; Niederau C; Ferrell LD
Pancreas; 1987; 2(2):181-6. PubMed ID: 2442741
[TBL] [Abstract][Full Text] [Related]
20. Serine proteases mediate inflammatory pain in acute pancreatitis.
Ceppa EP; Lyo V; Grady EF; Knecht W; Grahn S; Peterson A; Bunnett NW; Kirkwood KS; Cattaruzza F
Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G1033-42. PubMed ID: 21436316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]